Valbuena A, et al. (2007) Identification of a dominant epitope in human vaccinia-related kinase 1 (VRK1) and detection of different intracellular subpopulations. Arch Biochem Biophys 465, 219-26 17617371

This page summarizes selected information from the record referenced above and curated into PhosphoSitePlus®, a comprehensive online resource for the study of protein post-translational modifications (NAR, 2015, 43:D512-20). To learn more about the scope of PhosphoSitePlus®, click here.

Information from this record has been curated, but not yet edited in PhosphoSitePlus® and may be incomplete.

Click on the protein name to open the protein page, and on the RSD number to open the site page.

Download

S342-p - VRK1 (human) ▲

Modsite: DDGkLDLsVVENGGL SwissProt Entrez-Gene Orthologous residues VRK1 (human): S342‑p, VRK1 (mouse): S342‑p Characterization Methods used to characterize site in vivo:  mutation of modification site, phospho-antibody, western blotting Disease tissue studied:  lung cancer, non-small cell lung cancer Relevant cell lines - cell types - tissues:  NCI-H1299 (pulmonary) Cellular systems studied:  cell lines

T355-p - VRK1 (human) ▲

Modsite: GLkAKTItKKRKKEI SwissProt Entrez-Gene Orthologous residues VRK1 (human): T355‑p, VRK1 (mouse): S355‑p Characterization Methods used to characterize site in vivo:  mutation of modification site, phospho-antibody, western blotting Disease tissue studied:  lung cancer, non-small cell lung cancer Relevant cell lines - cell types - tissues:  NCI-H1299 (pulmonary) Cellular systems studied:  cell lines